[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6592 

# __Lack of conclusive evidence for the effectiveness of shl oral liquid against covid-19__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Emphasize the need for evidence-based treatments and cautious use of traditional remedies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8466.md)

## Name of the risk

Potential reliance on an unproven treatment for COVID-19

## People affected by this risk

* [And healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Medical practitioners](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2682.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3120.md)

## Stakeholders who can mitigate this risk

* [And healthcare organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1293.md)
* [Medical research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3087.md)
* [Regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4250.md)

## Technologies linked to the risk

* [Evidence-based clinical trials and research studies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8006.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

